Literature DB >> 28884397

BRCA1 gene: function and deficiency.

Miho Takaoka1, Yoshio Miki2,3.   

Abstract

The BRCA1 protein, a hereditary breast and ovarian cancer-causing gene product, is known as a multifunctional protein that performs various functions in cells. It is well known, along with BRCA 2, to cause hereditary breast and ovarian cancer, but here we will specifically focus on BRCA1. We introduce the mechanism and the latest report on homologous recombination repair, replication, involvement in checkpoint regulation, transcription, chromatin remodeling, and cytoplasmic function (centrosome regulation, apoptosis, selective autophagy), and consider the possibility of carcinogenesis from inhibition of the intracellular functions in each. We also consider the possibility of drug development based on each function. Finally, we will explain, from data obtained through basic research, that an appropriate regimen is important for raising the response rate for poly (ADP)-ribose polymerase inhibitors, in the case of low susceptibility, iatrogenic toxicity, tolerance, etc.

Entities:  

Keywords:  BRCA1; Gene mutation; Hereditary breast and ovarian cancer; PARP inhibitor

Mesh:

Substances:

Year:  2017        PMID: 28884397     DOI: 10.1007/s10147-017-1182-2

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  94 in total

1.  Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.

Authors:  Maria Rodriguez; Xiaochun Yu; Junjie Chen; Zhou Songyang
Journal:  J Biol Chem       Date:  2003-10-24       Impact factor: 5.157

2.  BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.

Authors:  Megan Fabbro; Stefan Schuechner; Wendy W Y Au; Beric R Henderson
Journal:  Exp Cell Res       Date:  2004-08-15       Impact factor: 3.905

3.  BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ.

Authors:  Rachel Litman; Min Peng; Zhe Jin; Fan Zhang; Junran Zhang; Simon Powell; Paul R Andreassen; Sharon B Cantor
Journal:  Cancer Cell       Date:  2005-09       Impact factor: 31.743

4.  Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity.

Authors:  H Ruffner; C A Joazeiro; D Hemmati; T Hunter; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

5.  Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase Inhibition.

Authors:  Stephanie Lheureux; Jeff P Bruce; Julia V Burnier; Katherine Karakasis; Patricia A Shaw; Blaise A Clarke; S Y Cindy Yang; Rene Quevedo; Tiantian Li; Mark Dowar; Valerie Bowering; Trevor J Pugh; Amit M Oza
Journal:  J Clin Oncol       Date:  2017-02-21       Impact factor: 44.544

6.  BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export.

Authors:  Megan Fabbro; Jose A Rodriguez; Richard Baer; Beric R Henderson
Journal:  J Biol Chem       Date:  2002-03-29       Impact factor: 5.157

7.  Fanconi Anemia Proteins Function in Mitophagy and Immunity.

Authors:  Rhea Sumpter; Shyam Sirasanagandla; Álvaro F Fernández; Yongjie Wei; Xiaonan Dong; Luis Franco; Zhongju Zou; Christophe Marchal; Ming Yeh Lee; D Wade Clapp; Helmut Hanenberg; Beth Levine
Journal:  Cell       Date:  2016-04-28       Impact factor: 41.582

8.  Cancer suppression by the chromosome custodians, BRCA1 and BRCA2.

Authors:  Ashok R Venkitaraman
Journal:  Science       Date:  2014-03-28       Impact factor: 47.728

9.  BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.

Authors:  Rinske Drost; Peter Bouwman; Sven Rottenberg; Ute Boon; Eva Schut; Sjoerd Klarenbeek; Christiaan Klijn; Ingrid van der Heijden; Hanneke van der Gulden; Ellen Wientjens; Mark Pieterse; Aurelie Catteau; Pete Green; Ellen Solomon; Joanna R Morris; Jos Jonkers
Journal:  Cancer Cell       Date:  2011-12-13       Impact factor: 31.743

10.  The interaction between CtIP and BRCA1 is not essential for resection-mediated DNA repair or tumor suppression.

Authors:  Colleen R Reczek; Matthias Szabolcs; Jeremy M Stark; Thomas Ludwig; Richard Baer
Journal:  J Cell Biol       Date:  2013-05-27       Impact factor: 10.539

View more
  33 in total

1.  Sae2/CtIP prevents R-loop accumulation in eukaryotic cells.

Authors:  Sucheta Arora; Yizhi Yin; Nodar Makharashvili; Qiong Fu; Xuemei Wen; Ji-Hoon Lee; Chung-Hsuan Kao; Justin Wc Leung; Kyle M Miller; Tanya T Paull
Journal:  Elife       Date:  2018-12-07       Impact factor: 8.140

2.  A BRCA1 Splice Site Variant Responsible for Familial Ovarian Cancer in a Han-Chinese Family.

Authors:  Peng-Zhi Hu; Xiang-Yu Chen; Wei Xiong; Zhi-Jian Yang; Xiao-Rong Li; Wen-Zhi Deng; Li-Na Gong; Hao Deng; La-Mei Yuan
Journal:  Curr Med Sci       Date:  2022-03-15

Review 3.  Functions of Breast Cancer Predisposition Genes: Implications for Clinical Management.

Authors:  Akiyo Yoshimura; Issei Imoto; Hiroji Iwata
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

4.  Meiotic Double-Strand Break Processing and Crossover Patterning Are Regulated in a Sex-Specific Manner by BRCA1-BARD1 in Caenorhabditis elegans.

Authors:  Qianyan Li; Sara Hariri; JoAnne Engebrecht
Journal:  Genetics       Date:  2020-08-12       Impact factor: 4.562

Review 5.  Selective Modulation of Dynamic Protein Complexes.

Authors:  Julie M Garlick; Anna K Mapp
Journal:  Cell Chem Biol       Date:  2020-08-11       Impact factor: 8.116

6.  Interaction of maternal immune activation and genetic interneuronal inhibition.

Authors:  Allison Anderson; Thiago C Genaro-Mattos; Luke B Allen; Katalin Koczok; Zeljka Korade; Karoly Mirnics
Journal:  Brain Res       Date:  2021-02-15       Impact factor: 3.252

7.  BBIT20 inhibits homologous DNA repair with disruption of the BRCA1-BARD1 interaction in breast and ovarian cancer.

Authors:  Liliana Raimundo; Angela Paterna; Juliana Calheiros; Joana Ribeiro; David S P Cardoso; Ilaria Piga; Susana Junqueira Neto; Denise Hegan; Peter M Glazer; Stefano Indraccolo; Silva Mulhovo; José Luís Costa; Maria-José U Ferreira; Lucília Saraiva
Journal:  Br J Pharmacol       Date:  2021-06-11       Impact factor: 9.473

Review 8.  Breast cancer in low-middle income countries: abnormality in splicing and lack of targeted treatment options.

Authors:  Flavia Zita Francies; Rodney Hull; Richard Khanyile; Zodwa Dlamini
Journal:  Am J Cancer Res       Date:  2020-05-01       Impact factor: 5.942

9.  Case report: Analysis of BRCA1 and BRCA2 gene mutations in a hereditary ovarian cancer family.

Authors:  Ying Liao; Chunhua Tu; Xiaoxia Song; Liping Cai
Journal:  J Assist Reprod Genet       Date:  2020-04-30       Impact factor: 3.412

Review 10.  HRness in Breast and Ovarian Cancers.

Authors:  Elizabeth Santana Dos Santos; François Lallemand; Ambre Petitalot; Sandrine M Caputo; Etienne Rouleau
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.